1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Skin cancer

Bifikafusp alfa–onfekafusp alfa for neoadjuvant treatment of 3B or 3C resectable melanoma [ID6384]

Awaiting development [GID-TA11458] Expected publication date: TBC

  • Project information
  • Project documents

6380-Daromun-for-Melanoma-V1.0-SEP2023-NON-CONF.pdf (nihr.ac.uk)